ALX vs EW · P/E 63, rev $108.1M vs P/E 47, rev $3.39B
Alexanders Inc (ALX) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Alexanders Inc (ALX) is a reit - retail company listed on NYSE.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ALX revenue for 2026-06-30 was $108.1M. Net income was $160.0M. ALX currently screens at market cap $1.30B and trailing P/E 63.5.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ALX currently screens at market cap $1.30B and trailing P/E 63.5. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ALX and EW stock pages for the full models.
Not investment advice.